Page last updated: 2024-10-29

iothalamic acid and Parkinson Disease

iothalamic acid has been researched along with Parkinson Disease in 2 studies

Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kandel, E2
Chebotaryova, NM2

Other Studies

2 other studies available for iothalamic acid and Parkinson Disease

ArticleYear
Conray ventriculography in stereotaxic surgery. Experience with 320 operations.
    Confinia neurologica, 1972, Volume: 34, Issue:1

    Topics: Athetosis; Basal Ganglia; Cerebral Ventriculography; Child; Dystonia Musculorum Deformans; Hepatolen

1972
Conray ventriculography in stereotaxic surgery experience with 320 operations.
    Confinia neurologica, 1972, Volume: 34, Issue:2

    Topics: Athetosis; Basal Ganglia; Cerebral Ventriculography; Child; Dystonia Musculorum Deformans; Evaluatio

1972